182 related articles for article (PubMed ID: 18198348)
1. Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells.
Gotoh K; Tanaka Y; Nishikimi A; Inayoshi A; Enjoji M; Takayanagi R; Sasazuki T; Fukui Y
Blood; 2008 Mar; 111(6):2973-6. PubMed ID: 18198348
[TBL] [Abstract][Full Text] [Related]
2. The role of Dock2 on macrophage migration and functions during Citrobacter rodentium infection.
Ji L; Chen Y; Xie L; Liu Z
Clin Exp Immunol; 2021 Jun; 204(3):361-372. PubMed ID: 33662140
[TBL] [Abstract][Full Text] [Related]
3. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
[TBL] [Abstract][Full Text] [Related]
4. Dimerization of DOCK2 is essential for DOCK2-mediated Rac activation and lymphocyte migration.
Terasawa M; Uruno T; Mori S; Kukimoto-Niino M; Nishikimi A; Sanematsu F; Tanaka Y; Yokoyama S; Fukui Y
PLoS One; 2012; 7(9):e46277. PubMed ID: 23050005
[TBL] [Abstract][Full Text] [Related]
5. DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis.
Kunisaki Y; Nishikimi A; Tanaka Y; Takii R; Noda M; Inayoshi A; Watanabe K; Sanematsu F; Sasazuki T; Sasaki T; Fukui Y
J Cell Biol; 2006 Aug; 174(5):647-52. PubMed ID: 16943182
[TBL] [Abstract][Full Text] [Related]
6. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration.
Fukui Y; Hashimoto O; Sanui T; Oono T; Koga H; Abe M; Inayoshi A; Noda M; Oike M; Shirai T; Sasazuki T
Nature; 2001 Aug; 412(6849):826-31. PubMed ID: 11518968
[TBL] [Abstract][Full Text] [Related]
7. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells.
Penna G; Vulcano M; Sozzani S; Adorini L
Hum Immunol; 2002 Dec; 63(12):1164-71. PubMed ID: 12480260
[TBL] [Abstract][Full Text] [Related]
8. DOCK2 and DOCK5 act additively in neutrophils to regulate chemotaxis, superoxide production, and extracellular trap formation.
Watanabe M; Terasawa M; Miyano K; Yanagihara T; Uruno T; Sanematsu F; Nishikimi A; Côté JF; Sumimoto H; Fukui Y
J Immunol; 2014 Dec; 193(11):5660-7. PubMed ID: 25339677
[TBL] [Abstract][Full Text] [Related]
9. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress.
Nombela-Arrieta C; Mempel TR; Soriano SF; Mazo I; Wymann MP; Hirsch E; Martínez-A C; Fukui Y; von Andrian UH; Stein JV
J Exp Med; 2007 Mar; 204(3):497-510. PubMed ID: 17325199
[TBL] [Abstract][Full Text] [Related]
10. DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration.
Shulman Z; Pasvolsky R; Woolf E; Grabovsky V; Feigelson SW; Erez N; Fukui Y; Alon R
Blood; 2006 Oct; 108(7):2150-8. PubMed ID: 16772603
[TBL] [Abstract][Full Text] [Related]
11. The Rac activator DOCK2 regulates natural killer cell-mediated cytotoxicity in mice through the lytic synapse formation.
Sakai Y; Tanaka Y; Yanagihara T; Watanabe M; Duan X; Terasawa M; Nishikimi A; Sanematsu F; Fukui Y
Blood; 2013 Jul; 122(3):386-93. PubMed ID: 23719299
[TBL] [Abstract][Full Text] [Related]
12. The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization.
Ippagunta SK; Malireddi RK; Shaw PJ; Neale GA; Vande Walle L; Green DR; Fukui Y; Lamkanfi M; Kanneganti TD
Nat Immunol; 2011 Sep; 12(10):1010-6. PubMed ID: 21892172
[TBL] [Abstract][Full Text] [Related]
13. Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.
Yasuda K; Nündel K; Watkins AA; Dhawan T; Bonegio RG; Ubellacker JM; Marshak-Rothstein A; Rifkin IR
Int Immunol; 2013 May; 25(5):295-306. PubMed ID: 23291967
[TBL] [Abstract][Full Text] [Related]
14. Role of DOCK2 and DOCK180 in fetal thymus colonization.
Lei Y; Liu C; Saito F; Fukui Y; Takahama Y
Eur J Immunol; 2009 Oct; 39(10):2695-702. PubMed ID: 19728314
[TBL] [Abstract][Full Text] [Related]
15. Dedicator of cytokinesis protein 2 couples with lymphoid enhancer-binding factor 1 to regulate expression of CD21 and B-cell differentiation.
Jing Y; Kang D; Liu L; Huang H; Chen A; Yang L; Jiang P; Li N; Miller H; Liu Z; Zhu X; Yang J; Wang X; Sun J; Liu Z; Liu W; Zhou X; Liu C
J Allergy Clin Immunol; 2019 Nov; 144(5):1377-1390.e4. PubMed ID: 31405607
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha differentially affects homeostasis of human plasmacytoid and myeloid dendritic cells.
Cicinnati VR; Kang J; Hou J; Lindemann M; Koop K; Tüting T; Gerken G; Beckebaum S
J Interferon Cytokine Res; 2009 Mar; 29(3):145-60. PubMed ID: 19196069
[TBL] [Abstract][Full Text] [Related]
17. Antigen Availability and DOCK2-Driven Motility Govern CD4
Ackerknecht M; Gollmer K; Germann P; Ficht X; Abe J; Fukui Y; Swoger J; Ripoll J; Sharpe J; Stein JV
J Immunol; 2017 Jul; 199(2):520-530. PubMed ID: 28607113
[TBL] [Abstract][Full Text] [Related]
18. The CDM protein DOCK2 in lymphocyte migration.
Reif K; Cyster J
Trends Cell Biol; 2002 Aug; 12(8):368-73. PubMed ID: 12191913
[TBL] [Abstract][Full Text] [Related]
19. The Rac Activator DOCK2 Mediates Plasma Cell Differentiation and IgG Antibody Production.
Ushijima M; Uruno T; Nishikimi A; Sanematsu F; Kamikaseda Y; Kunimura K; Sakata D; Okada T; Fukui Y
Front Immunol; 2018; 9():243. PubMed ID: 29503648
[TBL] [Abstract][Full Text] [Related]
20. Essential role of Elmo1 in Dock2-dependent lymphocyte migration.
Stevenson C; de la Rosa G; Anderson CS; Murphy PS; Capece T; Kim M; Elliott MR
J Immunol; 2014 Jun; 192(12):6062-70. PubMed ID: 24821968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
